An Open Label, Non-Interventional Study Of The Safety, Tolerability, And Efficacy Of Amlodipine And Olmesartan Medoxomil (NormetecTM) In Filipino Patients With Hypertension: A Post Marketing Surveillance Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Adverse reactions
Most Recent Events
- 17 Aug 2021 Biomarkers information updated
- 03 May 2012 Planned end date changed from 1 Apr 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 10 Feb 2012 Planned end date changed from 1 Jul 2012 to 1 Apr 2015 as reported by ClinicalTrials.gov.